Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation

NCT00487032 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Allergic Rhinitis
Tachyphylaxis
Rhinitis Medicamentosa

Interventions

DRUG: Oxymetazoline 0.05% w/v
DRUG: Fluticasone propionate 50 micrograms per actuation
DRUG: Prazosin hydrochloride
DRUG: Placebo to Prazosin

Sponsor

Brian J Lipworth